Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell–based therapeutics
Article 2024 en
Authors
MR
Mahendra Rao
JR
John E.J. Rasko
PR
Patrícia R. M. Rocco
Abstract
1 min read
By applying a Delphi method to establish a consensus definition for MSCs and reporting guidelines for MSC-based clinical trials, this work represents a significant advance in improving transparency and reproducibility in the conduct and reporting of MSC research.
Katharina Domschke, Patrik D. Seuling, Miriam A. Schiele, Borwin Bandelow, Neeltje M. Batelaan, Wicher A. Bokma, Igor Branchi, Karl Broich, Julius Burkauskas, Simon Davies, Bernardo Dell’Osso, Harry Fagan, Naomi Fineberg, Toshi A. Furukawa, Stefan G. Hofmann, Sean Hood, Nathan T. M. Huneke, Milan Latas, Nicky Lidbetter, Vasilios G. Masdrakis, R. Hamish McAllister‐Williams, Antônio Egídio Nardi, Stefano Pallanti, Brenda W.J.H. Penninx, Giampaolo Perna, Steve Pilling, Stefano Pini, Andreas Reif, Soraya Seedat, Gemma Simons, Shrikant Srivastava, Vesta Steiblienė, Dan Joseph Stein, Murray B. Stein, Michael Van Ameringen, Anton J.L.M. van Balkom, Nic J.A. van der Wee, Peter Zwanzger, David S. Baldwin
Xiaoxuan Liu, Samantha Cruz Rivera, David Moher, Melanie Calvert, Alastair K. Denniston, Hutan Ashrafian, Andrew L. Beam, An-Wen Chan, Gary S. Collins, Ara DarziJonathan J Deeks, M. Khair ElZarrad, Cyrus Espinoza, Andre Esteva, Livia Faes, Lavinia Ferrante di Ruffano, John Fletcher, Robert Golub, Hugh Harvey, Charlotte Haug, Christopher Holmes, Adrian Jonas, Pearse A. Keane, ,
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.